Search results

Liquid "ready for use", containing synthetic phospholipid blend. This kit is intended for use in the European Pharmacopoeia (EP) method for the detection of activated coagulation factors in therapeutic products. Also, the NAPTT reagent alone can be used in the NAPTT test for detecting contact activation and hypercoagulability (For Research Use Only).

Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.

Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.

Activated partial thromboplastin time (APTT) is a commonly used screening test for haemostatic defects in the intrinsic and common pathway of the coagulation cascade, as well as the contact activation system.

For PT/INR and PT% calibration

All research studies and protocols where a source of chromogenic substrate for Thrombin (FIIa) is required.

Thrombin (IIa), anti-rabbit, sheep, IgG, purified (polyclonal)

Thrombin (IIa), anti-human, sheep, IgG, purified (polyclonal)

Quantitative measurement of dabigatran, and anti-thrombin activities in plasma.

Quantitative measurement of dabigatran, and anti-thrombin activities in plasma.